Global Buccal Drug Delivery System Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Buccal Drug Delivery System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Buccal Drug Delivery System Market Size and Projected Growth Rate?
The market size for the buccal drug delivery system has seen quick expansion in the recent past. It is forecasted to inflate from $3.55 billion in 2024 to $3.91 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.3%. Factors such as initial innovations in drug delivery, acceptance by the pharmaceutical industry, clinical research and effectiveness, market entry tactics, and disease-specific applications contributed to the growth in the historic period.

The market size for the buccal drug delivery system is projected to undergo significant expansions in the upcoming years, potentially reaching a market value of $5.97 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%. The anticipated growth over the forecast period can be credited to many factors such as the focus on patient-oriented drug delivery, the increasing elderly population, the surge in demand for targeted therapies, biologics and peptides delivery, as well as support and approval from regulatory bodies, and the investment in research and development. Emerging trends within the forecast period comprise convenience and patient compliance, advancements in drug formulations, a rise in chronic illnesses, focus on pediatric and geriatric care, and improved bioavailability.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8290

What Are the Major Segments in the Buccal Drug Delivery System Market?
The buccal drug delivery system market covered in this report is segmented -

1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp

What Are The Driving Buccal Drug Delivery System Market Evolution?
The increasing incidence of chronic illnesses is anticipated to fuel the expansion of the buccal drug delivery systems market in the future. Chronic ailments are health conditions that last for over a year, such as cancer, heart disease, stroke, diabetes, and arthritis. These are the most common chronic diseases that can be controlled but not completely cured and require ongoing dietary and medical attention. Buccal drug delivery systems are perfectly suited for the administration of mucosal and transmucosal medications needed by a significant number of patients dealing with chronic diseases like diabetes and cancer. For example, in September 2023, as per the World Health Organization, a specialized agency of the United Nations based in Switzerland, there were 41 million deaths, accounting for 74% of total deaths caused by non-communicable diseases (NCDs) or chronic diseases worldwide each year. There were 17.9 million deaths due to cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the escalating incidence of chronic diseases is propelling the growth of the buccal drug delivery systems market.

Which Firms Dominate The Buccal Drug Delivery System Market Segments?
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Genere*x Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

What Trends Are Expected to Dominate the Buccal Drug Delivery System Market in the Next 5 Years?
Significant players in the buccal drug delivery systems market are primarily targeting the creation of novel remedies, like oral therapies for plaque psoriasis, to enhance patient outcomes and boost the effectiveness of drug distribution. Oral treatment for plaque psoriasis involves taking medication by mouth to handle and mitigate the signs of plaque psoriasis, a long-term autoimmune disorder characterized by fast skin cell growth resulting in thick, red, and scaly patches. For instance, Bristol Myers Squibb, an American pharmaceutical firm, gained FDA clearance for Sotyktu (deucravacitinib), an oral medication for adults suffering from moderate-to-severe plaque psoriasis in September 2022. This authorization signifies the dawn of a new oral treatment for this disease in almost ten years, introducing a unique mode of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Which Is The Largest Region In The Buccal Drug Delivery System Market?
North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Buccal Drug Delivery System Market?
2. What is the CAGR expected in the Buccal Drug Delivery System Market?
3. What Are the Key Innovations Transforming the Buccal Drug Delivery System Industry?
4. Which Region Is Leading the Buccal Drug Delivery System Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.